VMD Viemed Healthcare, Inc.
Platform & Compounding FCF
C+ 58.5 / 100 composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

Profitability

Weight: 25%
C- 49
  • 5yr Avg ROIC 8.6%
  • Operating Margin Trend -0.24 pp/yr

Capital Efficiency

Weight: 15%
C 57
  • 5yr Avg ROE 8.8%
  • 5yr Share-Count CAGR 0.1%

Growth Quality

Weight: 25%
C+ 57
  • 5yr Revenue CAGR 15.5%
  • 5yr EPS CAGR -14.7%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 20%
C+ 60
  • 5yr FCF Margin 4.3%
  • 5yr FCF/NI Conversion 0.77x

Balance Sheet

Weight: 10%
A+ 97
  • Net Debt / EBITDA 0.05x
  • Interest Coverage (EBIT/Int) 19.42x
  • Altman Z-Score 5.15

Stability

Weight: 5%
D 33
  • EPS Volatility (σ/μ) 1.12
  • Negative-Revenue Years (5) 1/5
  • Piotroski F-Score 4

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 2 gurus held; 1 added; 1 trimmed.

Holders
2
Avg Δ position
+6.1%
New buys
0
Full exits
0
As of Q2 2026